This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cavaillon, J.-M. Articles by Fitting, C. Search for Related Content PubMed Articles by Cavaillon, J.-M. Articles by Fitting, C. Social Bookmarking                         What's this?

Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10 and TGFβ

Unité d'Immuno-Allergie, Institut Pasteur, Paris, France

C. Pitton

Unité d'Immuno-Allergie, Institut Pasteur, Paris, France

C. Fitting

Unité d'Immuno-Allergie, Institut Pasteur, Paris, France

Administration of non-lethal doses of lipopolysaccharide (LPS) to experimental animals and humans results for a short period of time in a state of hyporesponsiveness to a second LPS challenge. This phenomenon, known as endotoxin tolerance, has been reproduced in vitro using human monocytes, rendered endotoxin-tolerant following a first incubation with LPS. A further activation by LPS was manifested by a dramatically reduced production of tumor necrosis factor (TNF). We report this low responsiveness of LPS pretreated monocytes as an endotoxin non-specific phenomenon. Indeed, TNF release upon further activation with either killed Gram-positive bacteria (Staphylococci, Streptococci) or zymosan was also significantly diminished. This was not the case when phorbol myristate acetate (PMA) was used as a second triggering agent, suggesting that the monocyte hyporesponsiveness due to LPS does not affect all activation pathways, particularly that of protein kinase C. On the other hand, both PMA and zymosan pretreatment could reduce a further activation of monocytes by LPS. We investigated whether the first signal(s) delivered by LPS, could be mimicked by some of the LPS-induced cytokines. Preincubation of monocytes with either interleukin-1 (IL-1), IL-10 or transforming growth factor β (TGFβ) lower the TNF production upon further activation with LPS. None of the cytokines alone was as efficient as the LPS molecule, but high levels of tolerization were obtained with combination of IL-1, IL-10 and TGFβ. Neither IL-6, IL-8 nor TNF led to hyporeactive cells. Our data indicate that endotoxin tolerance is not an LPS-specific phenomenon and that more than one cytokine can contribute to render human monocytes hyporeactive to further activation by LPS.

Journal of Endotoxin Research, Vol. 1, No. 1, 21-29 (1994)
DOI: 10.1177/096805199400100105


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. Silverstein, W.M. Johnson, S.E. Bucklin, and D.C. Johnson The protein kinase C activator PMA modulates LPS lethality in normal mice and protects against LPS lethality in D-galactosamine-sensitized mice Innate Immunity, February 1, 1996; 3(1): 29 - 37. [Abstract] [PDF]

				B. Zingarelli, M. Makhlouf, P.V. Halushka, A.P. Caputi, and J.A. Cook Altered macrophage function in tumor necrosis factor {alpha}- and endotoxin-induced tolerance Innate Immunity, August 1, 1995; 2(4): 247 - 254. [Abstract] [PDF]